To The Moon

As we move through 2026, the term "Mythos" has become synonymous with a radical industrial divide. Between Anthropic’s Claude Mythos (the digital disruptor) and Mythos AI (the physical autonomous pilot), the corporate landscape is being split into clear winners and losers. Below is an analysis of the specific companies poised to thrive and those most at risk. The Cybersecurity Frontier (Claude Mythos) The release of Claude Mythos in early 2026 proved that AI could find "zero-day" vulnerabilities at a scale humans cannot match. This creates a massive shift in the software and security sectors.   The Winners: Defensive Partners & Agile Giants The "Glasswing" Coalition: Anthropic’s controlled release (Project Glasswing) includes Amazon (AWS), Microsoft, Apple, Google, and Nvidia

When a critical chokepoint like the Strait of Hormuz is blocked, the market doesn't just react—it recalibrates. For a Dollar-Cost Averaging (DCA) investor, this is the time to ensure your monthly outlays are flowing into assets that either hedge against the disruption or possess the structural resilience to ignore the noise. The "Energy Hedge" ETFs If the Strait stays closed, energy prices may remain elevated for longer than the market currently predicts. Integrating energy-focused ETFs into your DCA plan can act as a natural hedge against the rising costs you'll see at the pump or on your utility bill.   Energy Select Sector SPDR Fund (XLE): Instead of betting on the commodity itself, this ETF holds the "blue chips" of energy (like ExxonMobil and Chevron). These companies often

$Bank of America(BAC)$ option assignment 

For many of us who have spent years watching the Straits Times Index (STI) move with the speed of a sleepy turtle, the last two years have been nothing short of a "face-rip" rally. After being the "underdog" for so long, seeing the STI smashing through all-time highs feels a bit surreal. If you’ve been holding our local banks and blue chips, your portfolio is likely looking the healthiest it has in a decade. But as the index cruises past the 3,600 and 3,700 levels, the "kiasu" instinct starts kicking in: Is it time to take profit, or is there still meat on the bone? 1. Top of the Cycle or a Long Overdue Re-rating? When a market hits an all-time high (ATH), the "fear of heights" is natural. But we need to look at the fundamentals versus the noise. The Valuation Reality: Unlike the S&P 5

As of mid-April 2026, the S&P 500 has surged to fresh record territory, closing above 7,000 for the first time and reaching 7,126 on April 17. The Nasdaq has also notched new highs, while the Dow has clawed back toward its peaks. This rally follows a volatile start to the year marked by a sharp correction in late March, driven largely by relief over a tentative U.S.-Iran ceasefire and resilient corporate earnings.But with the index now trading at elevated valuations, a critical question looms: Are investors pricing in flawless earnings delivery while downplaying persistent macroeconomic headwinds? The Earnings Optimism Driving the RallyThe bull case rests on exceptionally strong profit momentum. FactSet data shows analysts now project 18% year-over-year earnings growth for the full-yea

$MSTR 20260417 155.0 PUT$ expiry

Abbott Laboratories, a diversified healthcare giant with a 135+ year history, has faced investor frustration in early 2026. Its stock has pulled back sharply, trading around $95–$96 as of mid-April 2026 following a roughly 6% drop after Q1 results. The primary culprit? Continued weakness in the nutrition segment, which includes household names like Similac infant formula and Ensure adult shakes. This drag has overshadowed solid growth elsewhere, raising questions about near-term recovery and whether ABT remains a compelling long-term holding. The Nutrition Drag: What’s Happening?Abbott’s nutrition business has been a consistent underperformer. In Q4 2025, worldwide nutrition sales fell 8.9% year-over-year to $1.94 billion (9.1% organic decline), driven by U.S. market share losses—partly fr

In late February 2026, the United States and Israel launched airstrikes on Iran, igniting a conflict that quickly threatened the Strait of Hormuz, spiked oil prices, and sent shockwaves through global markets. As of mid-April, fighting continues amid fragile truce talks, while other wars—from Russia’s grinding invasion of Ukraine to the persistent Israel-Hamas conflict and civil wars in Sudan and Myanmar—rage on with no end in sight. Yet here we are: the S&P 500 has clawed back every loss from the Iran war’s opening salvos, sitting just a whisper below its all-time high around 7,000 and posting its best weekly gains in months. How is this possible? Wall Street, it seems, has a remarkable talent for compartmentalizing chaos. The market isn’t blind to the wars—it’s simply pricing in a fu

In the age of artificial intelligence, market concentration isn’t a warning sign. It’s the scoreboard.As of the close on April 14, 2026, the cap-weighted S&P 500 (SPY) has posted a blistering +29.07% return over the past year. The equal-weighted version (RSP), by contrast, has lagged badly. The raw RSP/SPY ratio sits at just 0.2893. Normalized to 100 at the start of 2020, it now reads 80.99—down 19.01% over six years. That gap isn’t noise. It’s the clearest evidence that a handful of mega-cap innovators have carried the entire index while the other 493 stocks have mostly watched from the sidelines. Yet here’s the contrarian truth most breadth hawks miss: this extreme concentration is not a bug in the system. It’s the logical outcome of an exponential technology shift. And the first cra

bank earnings season is kicking off right now, and honestly, I'm pretty optimistic about what the big six – JPMorgan Chase, Bank of America, Citigroup, Wells Fargo, Goldman Sachs, and Morgan Stanley – are likely to deliver for the first quarter of 2026. Analysts are calling for overall profits to rise around 5% year-over-year across the group. Revenues should grow in the mid-to-high single digits for most of them, which isn't flashy but feels reliable in today's environment.What’s driving this? Net interest income (that sweet spread between what banks earn on loans and pay on deposits) is still holding up nicely thanks to rates that, while lower than their peak, remain elevated after the Fed's cuts in late 2025. The Fed has kept the benchmark steady around 3.5-3.75% lately, with just one m